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1. Introduction
The Human Fertilisation and Embryology Bill 2008 (HFE Bill 2008) 
allows four different kinds of human admixed embryos to be created 
and used in research under licence from the regulator, the Human 
Fertilisation and Embryology Authority (HFEA). True hybrids, resulting 
from the mixture of human and animal sperm and egg, are one of the 
four and the kind that came closest to being rejected by Parliament 
through amendments tabled at Commons Committee Stage. However, 
the kind that attracted more attention even than true hybrids, largely 
because it is the kind that scientists have the most interest in pursuing 
currently, is the kind that is formed by the transfer of a human cell 
nucleus or the entire contents of a human cell into an enucleated 
animal egg cell. This process, cell nuclear replacement, is based on the 
technique pioneered at Roslin in 1996 using cell nucleus and egg from 
the same species (in the Roslin case sheep). Human admixed embryos 
of this kind have been called cybrids.
Scientists are interested in creating cybrids for a number of reasons. 
Two featured prominently in debate: to study how embryonic stem 
cells can be derived from an adult cell nucleus, with the long-term aim 
of using embryonic stem cells as the basis for developing stem cell 
therapies for a wide range of diseases and traumas; and to study 
genetic disorders through creating embryonic stem cells from an adult 
cell nucleus with the relevant mutation.
Interest in pursuing research using cybrid embryos grew through 2005 
and 2006 in the UK when it became clear that many of the research 
results based on the use of solely human material published by a team 
based in South Korea had been faked. Many scientists thought that 
cybrids were of little or no ethical significance. They were hopeful the 
Government would support this kind of research, under new legislation 
if necessary (there was some doubt as to whether it was allowed or 
not). Much to their dismay, at the end of 2006 the Government 
announced it intended to ban the creation of cybrids and some other 
kinds of hybrids.
This set the scene for a period of intense lobbying and debate on the 
question over the next eight months. At the end of this period the 
Government had changed its position to supporting such research 
under licence. This in turn set the scene for lively Parliamentary and 
public discussion of the issue.
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In his 2008 Easter Day sermon Cardinal Keith O'Brien launched a 
strongly worded attack on the HFE Bill, focusing on the proposal to 
allow the creation of human-animal hybrid embryos for research: 'One 
might say that in our country we are about to have a public 
government endorsement of experiments of Frankenstein proportion rl
The Government, under pressure from within as well as without (it was 
rumoured that three Catholic Cabinet members were considering their 
positions), agreed that clauses relating to this issue and two others 
would not be subject to party whip when amendments were tabled in 
the Commons. Most members of the Government did not however 
abandon their support for such research. Indeed, on the Sunday 
before the key Commons vote, Prime Minister Gordon Brown wrote a 
strongly worded article in The Observer in support of the research.
Like Cardinal O'Brien, Brown singled out hybrid embryo research as 
the key issue in the Bill: 'I  believe that we owe it to ourselves and 
future generations to introduce these measures and, in particular, to 
give our unequivocal backing, within the right framework of rules and 
standards, to stem cell research.'2
Prime Minister Brown's enthusiasm for embryo stem cell research led 
critics to ask what had happened to change the Government's mind, 
and whether the change meant that respecting public sensibilities 
based on notions of the special status of the human embryo and 
human dignity had been abandoned.
Such questions do in part beg the scientifically and philosophically 
prior question of jus t what human admixed embryos are. The new HFE 
Bill has created a distinct category of human admixed embryos. For 
the purposes of the new Bill they are not regarded as human embryos 
though they will be regulated as if they are. The HFEA has interpreted 
the existing law so as to class cybrid embryos as human embryos and 
has licensed research on this basis. The distinctions are interesting in 
themselves. They are also important for examining the rationales for 
regulation.
1 The text of the speech is available online at:
htto://tim escolum ns.tvpepad.com /qledhill/2008/03/cardinal-stop-t.htm l (accessed 3
http://www.auardian.co  
(accessed 3 june 2008).
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Human embryos are in short supply and sourcing fresh human eggs in 
sufficient quantities to make cloned embryos is particularly difficult and 
not entirely risk-free for the women concerned. Accordingly, the 
impact of the various barriers, practical, ethical (of more than one 
kind), regulatory and otherwise on research using fully human material 
is not easy to judge. The raw materials used to create cybrids are, by 
contrast, in abundant supply and can be sourced without risk. Will 
researchers wishing to create human admixed embryos be subject to 
the same regulatory barriers, in practice, as those wishing to use fully 
human materials? Generally, what might we learn from the way 
regulation works in practice?
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2. Literature Review and Analysis
2.1 Approach and methodological issues
The research for the dissertation is informed by a grounded theory 
approach, which is well suited to the subject matter under study -  a 
process characterised by conflict and contestation leading to the 
construction and reconstruction of narratives and political 
compromises. As Strauss and Corbin put it:
Grounded theory is an action /  interaction oriented method of 
theory building. Whether one is studying individuals, groups, or 
collections, there is action /  interaction, which is directed at 
managing, handling, carrying out, responding to a phenomenon 
as it exists in context or under a specific set of perceived 
conditions. (Strauss and Corbin, 1990, p. 104).
In these terms the phenomenon under study is the governance 
framework for embryo research in the context of political debate and 
conflict over hybrid embryos. Strauss and Corbin argue that in the 
grounded theory approach to study 'one does not begin with a theory, 
then prove it. Rather, one begins with an area of study and what is 
relevant to that area is allowed to em erge/ (Strauss and Corbin, 1990, 
p. 23). The approach to study outlined by Strauss and Corbin is 
reflected in part in the structure of the finished dissertation. After a 
discussion of the nature of the governance framework (2.2) the 
literature review then contains a section on the evolving debate on the 
governance framework in the period 2006 -  2008, with particular 
focus on the different actors involved and the discussion of admixed 
human embryos (2.3). This is followed by an analysis of the current 
situation (2.4). Sections 2.3 and 2.4 were used to guide semi­
structured interviews with key participants in the debate. The review, 
analysis and interviews in turn informed sections 4 and 5, which are 
more thematic though still grounded in detailed description.
In his well-regarded study, The embryo research debate: Science and 
the politics o f reproduction, Mulkay (1997) has chronicled the embryo 
research debate of the late 1980s leading up to the HFE Act 1990. His 
book was based on many years of study and on a substantial number 
of published academic papers. In the book itself he adopted a 
historical narrative style, presenting 'a richly descriptive account of the 
debate which is informed by the relevant academic literature, but 
which is not encumbered by constant reference to academic issues/ 
(Mulkay, 1997, p. x). As one would expect his approach in the book
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was not out of step with that taken in the academic papers that 
informed it. In one such paper he explained his approach: 'I  will show 
that this victory [fo r the supporters of embryo research] was 
accompanied by the formal definition of moral boundaries within which 
embryo research was required to operate; by the establishment of 
social mechanisms for the maintenance of these boundaries; and by an 
apparent transfer of ultimate control over embryo research from the 
scientific and medical community to Parliament/ (Mulkay, 1994, p. 
197).
In this dissertation the approach adopted by Mulkay is broadly 
followed: thematic analysis is embedded in a description and 
discussion of the unfolding debate, and attention is focused on the 
reworking of old and establishment of new boundaries and social 
mechanisms of control. However, the engagement with Mulkay's study 
is a critical one. It seems fairly clear that Mulkay's analysis was 
informed by a degree of sympathy for critics of embryo research, 
which occasionally, to this reader, skews the analysis. The word 
'apparent' might be highlighted in the above quote; control was 
'apparently' transferred from scientists to politicians he says. Many 
practising scientists would argue strongly that there is nothing 
apparent about it. To give one more example: he appears to slip from 
arguing that a major factor in the victory of those lobbying in favour of 
embryo research was their promise to allow women at risk of having a 
child with a genetic condition the choice to avoid that, to arguing that 
the promise was that embryo testing could eliminate genetic disease 
from society (a quite different claim) (Mulkay, 1997, p. 63, p. 132). 
Perhaps based upon the idea that the latter claim was key he writes of 
'the utopian assumptions underlying the pro-research rhetoric of 
hope.' (Mulkay, 1997, p. 132).
Embryo research is a controversial and contested issue. Forms of 
public reason that appear to or do play a role in debate need to be 
analysed carefully. The construction of the framework underlying the 
1990 Act was strongly influenced by the Warnock Report (Warnock, 
1985). But as Mulkay and other have shown in detail it was also 
shaped by a series of polarised debates in Parliament in the second 
half of the 1980s. These debates embedded and strengthened the 
importance of the framework outlined by Warnock in many ways, and 
in doing so told us something about the reasons for its success. But 
the process of argument and debate also highlighted conflicting 
aspirations that remained, sometimes half-hidden. A similar pattern of 
reflection by various bodies and conflict characterised the debate over 
the HFE Bill 2008.
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One feature of the recent debate, reflecting the fact that the new Bill 
was an update of the old one, was the way in which the existing 
governance framework served as a reference point and a political 
resource during debate. Rather than debate over the merits of it, the 
dominant trend was to work with it and to use it. This created an 
impression of continuity; an impression that is in part deceptive. The 
extent to which changes in the content of the governance framework 
have occurred during these debates or perhaps come into clearer view, 
and the extent to which there is also continuity, is the central concern 
of this dissertation.
2.2 What is the nature o f the governance framework as it  emerges 
from the intense debates o f the last two years?
An assessment of continuity and change in the governance framework 
will depend on what is considered to be the essence of the framework, 
and what makes an assessment of the changes difficult is that it is far 
from easy to pin down the essence of the framework itself. The 
framework has a philosophical aspect to it, but it is also quite 
subjective and highly political both in its foundation and in its use. I t  is 
common to find the framework criticised but also held up as an ideal. 
Accordingly statements made about it require interpretation.
Many critics of embryo research perceive the UK regulatory system to 
be one of the most 'permissive' and research friendly in the world. In 
principle however it is quite restrictive, irrespective of how things work 
in practice. The Warnock Report stated that research is a matter of 
public interest and concern; that unlike in fertility treatment where 
'there was a fairly strong view that the freedom of the individual to 
take what steps he could had to be respected... in the case of research, 
on the other hand, there was general agreement that the issue of 
individual liberty did not arise.' (Warnock, 1985, p. xiv).
This underlying assumption is clearly present in the broad parameters 
of the governance framework. Schematically, four elements could be 
highlighted as defining the original framework: (i) embryos have a 
special status requiring protection in law and a licensing system to 
govern their use; (ii) research using human embryos is illegal unless 
permitted for specified purposes; (iii) researchers must show that it is 
necessary or desirable to use human embryos in each case; and (iv) 
some research purposes are illegal and cannot be licensed.
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In Parliamentary debate Andrew Lansley MP (Shadow Secretary of 
State for Health) argued that research using certain kinds of hybrid 
embryo would breach the existing framework because insufficient 
attention had been given to (iii) and (iv) above; the Government had 
maintained (i) formally, he said, but by permitting classes of research 
for which no case had as yet been convincingly made and lifting most 
prohibitions, it had overstepped the mark.3 Evan Harris MP (Liberal 
Democrat), a champion of research, disagreed. He maintained that the 
existing framework was intact because (i) remained unchanged and 
(iii) would apply to any class of embryos if and when applications were 
made for their use, which he saw as being the defining aspect of the 
framework.4
These observations, against a background of a schematic presentation 
of the nature of the Warnock framework, have some value, but to 
develop and situate them it is necessary to add to the picture.
Mary Warnock, architect of the framework that was substantially 
integrated into the 1990 Act, argued that in-vitro embryos should be 
accorded some respect and protection in law, but not the absolute 
protection we grant human life after birth. In proposing to allow 
research Warnock rejected the Pro-Life position. Less well known is 
that she also rejected the argument from potential. This is a 
complicated subject, not least because there are several arguments 
from potential and also because the arguments presented by Warnock 
are in her own introduction to the report rather than the report itself, 
leaving the question of what Committee members thought somewhat 
open.5 Nevertheless, it seems fairly clear that Warnock herself argued 
that the embryo had to be judged on what it is rather than what it 
would or could become, and what is more she argued that this was the 
view of the majority on the committee:
The majority of the Committee was not moved by the argument 
that these cells could, if certain conditions were satisfied, 
become human beings. They did not rely, that is to say, as the 
minority did, on 'potentiality', but on the consideration of what
3 Commons Hansard , 12 may 2008, columns 1073-1078.
4 Commons Hansard, 12 may 2008, column 1139.
5 As Michael Lockwood pointed out shortly after the report was published, in the body 
of the report we are given 'arguments for and against various positions, and we are 
given conclusions. But the relationship between the two often remains obscure/ See 
M Lockwood, 'Warnock Versus Powell (and Harridine): When Does Potential Count?', 
Bioethics, (1988 ), Volume 2, Number 3, p. 187.
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the embryo was at a particular time, its actual mode of existence 
immediately after fertilisation. (Warnock, 1985, p. xv).
This might seem clear and definitive enough. Warnock however 
advanced a second line of argument, or a second order argument: 
within society, sentiment attaches to such embryos and at a 
fundamental level sentiment is the basis of morality (Warnock, 1985 
and 1987).6
This view has been criticised by a number of philosophers, notably 
John Harris. How is this, he asks, a moral argument? And how is 
sentiment to be judged -  should we respect prejudice on this basis? 
(Harris, 1998). However, the key to Warnock's success was and 
remains that in the realm of practical politics it worked well; it 
facilitated and legitimated the process leading up to a vote insofar as 
the vote in Parliament was an expression of the sentiment of MPs and 
the conflicting desire to harmonise scientific advance with morality, 
specifically, back then, support for the family.
Clearly then, there are a number of issues in play. Reflecting on the 
1980s debate, Mulkay was of the view that the Warnock Report argued 
for external regulation of embryo research by reference to 'the need to 
protect the human embryos used for experimental purposes, the need 
to safeguard the public interest and the need to allay widespread 
anxie ty / (Mulkay, 1997, p. 20). Similarly, Ruth Deech, former chair of 
the HFEA and now a member of the House of Lords, outlines, in the 
context of discussing embryo stem cell research using fully human 
material, several reasons that may underlie the decision to regulate 
and restrict embryo research: a loss of potential for development; the 
symbolic harm to society resulting from embryo destruction -  'if  this is 
the way we are willing to treat the most vulnerable and helpless 
members of the human species, what does it say about us as moral 
beings?'; to appease those who feel the research is wrong; and out of 
respect for the effort taken to secure the material on which research is 
conducted. (Deech and Smajdor, 2007, pp. 195-6).
6 Lockwood argued that Warnock's rejection of the argument from potential was at 
odds with the views of the Committee expressed in the report. I disagree with this. 
She may have argued differently from some of the Committee, though for the reason 
given concerning the nature of the report this is hard to judge, but there is no 
contradiction as such. The key point is to distinguish between arguments based on 
potentiality and arguments based on the sentiments that people may hold about, 
among other things, the potential of the embryo.
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Some writers have attempted to make a judgement about which 
factors appear to be most important, and changes that may have 
occurred over time.
Writing in 1999, the distinguished legal scholar Margaret Brazier, an 
opponent of embryo research, gave emphasis to the third factor 
highlighted by Mulkay and suggested that in reality the embryo used in 
research was accorded no status: 'Are embryos in reality now treated 
any differently from laboratory artefacts, and treated with caution only 
because of their tendency to generate moral panic?' (Brazier, p. 187).
Brazier feared they were treated in such a way, though she was 
somewhat equivocal about whether this was the case. She was aware 
that her side had, as she put it, 'lost the war' on the basic question of 
research, but didn't think it acceptable that they should have to 
'simply shut up' as a consequence. Embryos as laboratory artefacts 
was, she argued, 'an .unacceptable resolution of the debate or basis 
for research.' (Brazier, 1999, p. 188). Brazier was however quite clear 
about one thing: 'Warnock was very bothered about embryos. Who 
cares any more? Embryo research has flourished in the United 
Kingdom.'(Brazier, 1999, p. 186).
If it was a war, Martin Johnson, now Professor of Reproductive 
Sciences, University of Cambridge, was on the winning side. As a 
member of the Progress campaign in the 1980s he helped to steer the 
Bill through Parliament. He has been a member of the HFEA and in 
2007 he was scientific advisor to the jo in t Parliamentary Committee 
(Commons and Lords) set up to scrutinise the draft Bill published by 
Government (hereafter called the Scrutiny Committee). In a series of 
papers written over the past two years, some in collaboration with 
Australian lawyer Kerry Petersen, he has developed the argument that 
today, if not in the 1980s, a distinction is made, which he would like to 
develop further, in regulation and practice between the embryo that is 
used in treatment and the embryo used in research. The latter, he 
believes, has little or no moral status. In other words, the issue of 
interest is not any inherent properties the embryo might have but 
what is done with it -  intention is the important thing. As a supporter 
of research he argues that a special regulatory structure governing 
research is and can only be justified by a public interest in reassuring 
people: 'Given that, in our view, the sole continuing justifiable public 
interest for the present cumbersome regulatory system is the socio­
political one of allaying fears, the continued existence of the HFEA as a 
confidence-inspiring body does seem crucial.' (Johnson and Petersen, 
2008, in press).
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Given its inherently political character, the Warnock framework 
contains the possibility of mutation and development. Taken as a 
whole Johnson's and Brazier's analyses in particular seem to point not 
simply to an evolution of the governance framework, but also to a shift 
in focus -  away from the status of the embryo as such to other 
rationales for regulation and restriction of research. This analysis is 
reinforced by the observation that when Government, in publications, 
and Government Ministers, in debate, did address the specific issue of 
the status of the embryo in the period 2006 to the present they tended 
to stress the idea of setting boundaries to respect a plurality of views, 
in order both to support research and reflect public concerns.7 This is > 
not a dramatic change from the Warnock framework, which was, after 
all, in large part premised on respecting the sentiments present in 
society. But it is less focused: a plurality of views rather than a 
particular view regarding the status of the embryo is commonly 
presented as a reason to allow research with restrictions and 
regulations when the status of the embryo itself is considered.
One continuity between 1990 and today is the claim made by 
Government and the regulator that the UK system is a model for the 
world, facilitating world-leading research through being at the forefront 
of regulatory practice. Government Ministers made this point 
repeatedly in the Parliamentary debates and during evidence sessions 
to Parliamentary inquiries.8 Ruth Deech makes a similar point, 
specifically about embryonic stem cell research and in general:
From this period [2001] the UK has led the world in both 
advancing and monitoring stem cell research. The basis on which 
it does so is that established by the HFEA in 1991 for the 
regulation of IVF and embryo storage. (Deech and Smajdor, 
2007, p. 28).
As we shall see in section 4 below, this view is not shared by some of 
the leading research scientists involved in the work.
2.3 Who were the key social actors and agents shaping the debate on 
human admixed embryos in particular? What were their motivations 
and priorities?
7 See for example Department of Health, 2006, p. v and Alan Johnson's speech 
introducing the Second Reading of the Bill in the Commons, 12 may 2008.
8 As an example, see Lord Darzi's speech introducing the Second Reading of the HFE 
Bill in the Lords, 19 may 2007.
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Parliamentarians have played an important role in recent debates, 
sometimes responding to pressure from scientists and campaigners for 
and against new developments, sometimes acting on their own 
initiative (relatively speaking). There was a general, if not 
overwhelming, sense among politicians that developments in science 
and a number of legal challenges to the HFE Act indicated that the 
time was ripe to look at the whole area of human reproduction again.
In 2002 the House of Commons Science and Technology Committee 
took a preliminary look and published a brief report (House of 
Commons Science and Technology Committee, 2002). In response the 
Government announced its intention to review the Act. The Committee 
then launched a bigger inquiry (House of Commons Science and 
Technology Committee, 2005a and 2005b). This helped to initiate over 
three years of further discussion.
Broad support for the principle of research using fully human embryos 
within limits and under licence was evident throughout these 
discussions. Indeed opponents of embryo research did not mount a 
challenge to it. However, over the course of the period autumn 2006 
to spring 2008, human admixed embryos became one of the major 
issues in the public and Parliamentary debates on the HFE Bill. The 
issue took on a symbolic and strategic significance for all the actors 
involved, well beyond the importance of the work in its own terms.
The broad political and policy context in which all groups operate today 
is different in some key regards from the 1980s. Back then, Pro-Life 
views were influential in society, and were very well represented within 
Parliament. This constituency has less influence today, in part due to 
the decline in traditional conservative views. At the same time, worries 
about a runaway world, of science being out of control, have 
strengthened. When concern is expressed about embryos today it is as 
likely to be concern about 'slippery slopes', dignity and 
'instrumentalism ' as it is to be a straightforward expression of belief in 
the sanctity of embryonic life.
These themes are present in the academic literature as well as in 
popular discussion. Concern about human dignity is central to Francis 
Fukuyama's famous book Our Posthuman Future (Fukuyama, 2002). 
Fukuyama takes Huxley's Brave New World very seriously; it is not, as 
it is for most people, a dystopian novel not to be taken too literally, 
but rather a prescient analysis of one distinctly possible future. Such is 
the threat posed by the biotechnology revolution, argues Fukuyama, 
that it might change human nature and re-start history (recall
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Fukuyama's even more famous book, The End o f History and the Last 
Man). Fukuyama does not however oppose embryo research entirely 
and indeed in Beyond Bioethics: A Proposal fo r Modernizing the 
Regulation o f Human Biotechnologies (Fukuyama and Furger, 2006) it 
is hybrid embryo research in particular that he thinks should be totally 
blocked.
The dangers of instrumentalising embryonic life is the dominant theme 
in Jurgen Habermas' book The Future of Human Nature (Habermas, 
2003). Habermas' concern is that once we start instrumentalising the 
embryo there is no stopping (Habermas, 2003, p. 71). Today's choices 
have to be assessed in the light of future possibilities, and these 
include, he fears, a fully eugenic future, in which their parents 
genetically design children. This is particularly problematic, he 
believes, not so much because a particular genetic constitution is 
better than any other, but because for a person to engage with others 
they must feel that they are inexchangeable, and this in turn requires 
that their body is experienced as something natural and non-designed.
In their different ways both Fukuyama and Habermas express strong 
concerns about embryo research without invoking ideas based on the 
sanctity of embryonic human life. Roger Brownsword labels this new 
alignment of old and new opponents of embryo research the 
'Dignitarian Alliance' (Brownsword, 2004a and 2004b). Unlike previous 
absolutist arguments based predominantly on Pro-Life grounds, the 
arguments put forward by this alliance do not clearly support outright 
rejection of embryo selection and research, or at least not all research.
For Pro-Life opponents of embryo research operating in this context, 
opposition, specifically, to hybrid embryo research expresses a number 
of aims and aspirations. Hybrid embryo research is something they 
genuinely oppose. But opposition, or at least the focus on this issue, is 
also both a strategic move to try to connect with an issue of particular 
general concern and an expression of frustration about their reduced 
influence and their inability to press their core concern. UK group 
Comment on Reproductive Ethics labels itself a secular organisation 
despite the affiliations of its co-founder, the well-known campaigner 
Josephine Quintavalle. As an individual, Quintavalle does not shy away 
from stating her Pro-Life views, especially when asked. But in recent 
debates her focus has largely been on hybrid embryos with an 
emphasis on scientific arguments, stressing the uselessness of the 
research, the claim that Government is ignoring the framework 
developed by Warnock in the 1980s, and the danger of pursuing 
research in the face of (reaf & perceived) public anxiety.
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It is not only opponents of the research for whom hybrid embryos took 
on a symbolic significance. Similarly, it appears that hybrids came to 
symbolise a mixture of hope and frustration for advocates of the 
research.
For a very brief period, perhaps as little as a week in autumn 2006, 
some scientists tentatively expressed the hope in public that maybe 
hybrid embryos could be viewed as a research tool that fell outside of 
the Warnock framework due to the fact that they were non-viable and 
thus non-human under the terms of the Act (for a researcher's 
reflections on this, after the event, see House of Commons Science 
and Technology Committee, 2007b, pp. Ev70-Ev71).
The researchers interested in pursuing the work were genuinely 
shocked and some were quite angry when the Government proposed 
neither simply to allow hybrid embryo research nor to regulate it 
through the HFEA but instead to outlaw it. Faced with a proposed ban, 
they saw little option but to frame such embryos as human embryos 
that the HFEA might license and to launch an intense lobbying 
campaign.
Indeed, supporters of embryo research made this a defining issue 
among all those under discussion in the White Paper and later the 
Draft Bill, one that they were determined not to lose. Within the 
current Warnock framework -  which requires a demonstration that 
embryo research is necessary or desirable -  it is arguable that this led 
to an exaggeration of the significance of the work.9
Frustration about the fact that plans for a re-fashioning of the 
Governance framework for research and treatment more broadly in a 
more liberal and a more 'evidence-based' direction had been rejected 
by Government perhaps also played a role in focusing campaigners in 
favour of research on the issue of hybrids.
The Bill as it stands at the time of writing in September 2008, after the 
Commons Committee stage, substantially reflects the proposals that
9 In an interview in the Daily Telegraph, 12 may 2008, a week before the votes in 
the Commons on the relevant clauses of the Bill, fertility expert Lord Winston 
questioned some of the hype: 'if the hybrid embryo thing doesn't go through, it in no 
way shakes the body of science... It's  a nice adjunct; a useful extra. But if we don't 
have that resource, it won't fundamentally alter the science of stem cell biology.' 
Available online at: http://w w w .teleqraph.co.uk/new s/1948802/Fertilitv-exDert-Lord- 
W inston-'relaxed'-about-embrvo-bill-failure.html (accessed 5 june 2008).
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emerged in the summer of 2007 from the Scrutiny Committee, chaired 
by Phil Willis MP. Concretely and most notably Willis' Committee 
convinced the Government to support a wide range of hybrid embryo 
research and also to drop plans to merge the HFEA with the Human 
Tissue Authority. Less commented upon however is the fact that Willis, 
who was also chair of the Commons Science and Technology 
Committee at the time, effectively buried the more radical proposals 
that had emerged from that Committee in 2005 when it was chaired 
by his predecessor, Ian Gibson MP.
In its 2005 report the Science and Technology Committee set itself the 
task of considering, among other things, 'the balance between 
legislation, regulation, and reproductive freedom / (p. 4). With the 
explicit or tacit support of some of those who would campaign in 
favour of the Bill three years later, the Committee gave a fair degree 
of support to the idea of'reproductive freedom', and also, to a lesser 
degree, the freedom to research, when it published its findings. It 
argued that in the absence of evidence of harm, people should be able 
to pursue reproductive options and researchers should be able to 
pursue novel lines of inquiry. Accordingly, among other proposals it 
expressed sympathy for the idea of sex selection on purely social 
rather than medical grounds and endorsed the creation of hybrid 
embryos for research.
In effect, the Science and Technology Committee recommended that 
most conceivable research applications be allowed in principle, so long 
as the creations were destroyed by 14 days. Contrary to the approach 
taken by Government, the Science and Technology Committee 
proposed a slimmed-down and faster system of regulation, with a 
greater emphasis on trusting professionals to follow the law. Indeed, in 
principle the Committee suggested that the law itself could be changed 
so that research using embryos should be broadly permitted except for 
specific prohibitions (to be decided), effectively abolishing the system 
of regulation run by the HFEA. But, in part concerned not to endorse 
'frivolous' uses of embryos, it left this somewhat open (pp. 81-82 and 
148-149). .
Such ambiguities hint at internal conflict on the Committee, and 
indeed there was plenty of that. Of particular general note is that a 
draft of the final report explicitly considered embracing a human rights 
or'libertarian' approach to the regulation of treatment (though not 
research). After internal dissent this was scrapped and the Warnock 
framework was endorsed in the key paragraph in the published report, 
though without a substantial re-write of the whole document, which
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was one reason given by a minority of Committee members for their 
decision to dissociate themselves from it.10
The Government was, generally speaking, unimpressed by the more 
radical proposals contained in the published report. In Parliamentary 
debate in July 2006 and in the White Paper of December 2006 it made 
clear that while some of the Science and Technology Committee's 
specific proposals might be entertained, others, such as the 
Committee's sympathy for social sex selection, would not be. 
Furthermore, the Committee's general suggestions bearing on the 
basis of regulation were rejected. In what might be read as a teasing 
comment, and certainly a significant one, the Government noted and 
welcomed the Committee's endorsement of the Warnock framework 
(Department of Health, 2006, p. 2), and took this to entail a wider 
agreement on the virtues of the UK system of regulation. This was an 
early example of the use of the Warnock framework as a political 
resource in debate. Since then everyone involved in the debate has 
endorsed it, whether for genuine of tactical reasons.
Overall, little argumentation was presented by Government, and 
perhaps any chance for a substantive discussion was lost in the furore 
around one specific proposal in the White Paper: the proposal to 
outlaw the creation of hybrid embryos for research.
The proposed ban came out of the Department of Health. One month 
later, signs that other parts of Government might be a little more 
sympathetic to the scientists' cause began to emerge. On 5 January 
2007 Prime Minister Tony Blair was quoted by the BBC as saying that 
it might need to be looked at again: 'I'm  sure that research that's 
really going to save lives and improve the quality of life will be able to 
go forward.'The HFEA, perhaps emboldened by such hints, decided at 
a licensing committee meeting five days later not to follow the line of 
the White Paper but instead to defer a decision on two applications to 
pursue the work pending a public inquiry it planned for the spring. By 
this point a lobbying campaign in favour of the work was in full swing, 
coordinated by Evan Harris MP. Harris was also a member of the
10 Robert Key, a Conservative MP and a member of the Committee who supported 
the final report was critical of the dissenting minority and generally embarrassed 
about the public falling out. Minority reports were one thing he said, and not all than 
unusual, but in this case the minority hadn't produced one. Rather they had publicly 
dissociated themselves from the whole report. He suggested that after the 
forthcoming general election only committed, enthusiastic and dedicated members 
should apply to join the Committee, promising 'normal service will then be resumed 
to Parliament, to the public and to the scientific community.' Robert Key, Hot Flush 
Over HRT, THES, 1 april 2005.
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Science and Technology Committee. In parallel with private and public 
lobbying he played a prominent role in the quick inquiry that the 
Committee organised into the issue.
The Science and Technology Committee inquiry performed a 
transitional role in a double sense: it started the process of pushing all 
branches of Government towards allowing research using the full 
range of hybrids; it also began the process of removing the more 
liberal and 'evidence-based' proposals floated in its own 2005 report 
from the policy agenda. In the latter sense it was transitional to the 
Scrutiny Committee's proposals and the approach embodied in the Bill. 
Contrary to the initial instincts of some of the scientists, in its report 
(House of Commons Science and Technology Committee 2007a) the 
Science and Technology Committee was very keen that hybrids should 
be considered human and regulated by the HFEA. Generalising from 
the findings of case law on fully human cloned embryos, the possibility 
that hybrids might fall outside the regulatory framework was highly 
undesirable, they argued (para. 71), despite the fact that outwith the 
remit of the HFEA, researchers using such entities would still be 
regulated by other means: there would be criminal laws prohibiting 
implantation of such entities into a woman, which were considered 
non-viable in any case. Apparently of the view that the public are a 
fearful if not irrational crowd liable to believe in ancient myths, the 
Committee argued that 'clear regulation in terms of what may and 
may not be permissible is necessary, for example in alleviating 
possible public fear that research of this nature may lead to the 
creation of half animal-half humans.' (para. 91).
The Scrutiny Committee picked up where the Science and Technology 
Committee left off on the issue of hybrids, but it had the wider remit of 
covering the entirety of issues covered in the draft Bill published by 
Government in May 2007. In terms of embryo research, it secured 
agreement from the Government to permit many of the concrete 
changes proposed by the Science and Technology Committee in 2005, 
but it did so through embracing at least some of the key principles of 
the governance framework that mark out embryo research as an area 
of specific concern subject to particular and at times quite burdensome 
regulatory principles and practices. In particular in the cause of 
defending hybrid embryo research and fighting off the proposed 
merger of the Human Tissue Authority and the HFEA the Committee 
and leading scientists issued ringing public endorsements of the HFEA 
and the merits of the Warnock framework.
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The Scrutiny Committee was not the only body examining the issue 
around this time. As already mentioned, in parallel with the Scrutiny 
Committee the HFEA, now back in a driving role, led a public 
consultation on the issue, the most expensive consultation it has even 
undertaken.
A deliberative approach including a public consultation was cited as the 
background for the proposals in the White Paper, published in 
December 2006, including the proposed ban on the creation of hybrid 
embryos for research (Department of Health, 2006). More favourable 
public opinion expressed during detailed and informed consultation and 
deliberation (Human Fertilisation and Embryology Authority, 2007; 
Warburton, 2007) along with a reasoned case made by scientists is 
one explanation for the shift in the Government's position. I t  is 
doubtful whether the process would come close to meeting the 
exacting standards set for deliberation and public reason found in 
some of the key texts on the subjects (such as Habermas, 1990 and 
Rawls, 2005). However, such a comparison would probably miss the 
point: the public were still quite doubtful about allowing research using 
hybrids in the results published by the HFEA, but it was also clear that 
objections were not strongly held, that people could be won round 
through an emphasis on the medical benefits that m ight follow the 
research. The decisive factor seems to have been a change of heart at 
the top: there is much anecdotal and suggestive evidence that the 
regulator, and by this time Government, was committed to interpreting 
the consultation so as to allow research, if at all possible.11
The most significant thing about the HFEA consultation in 2007 was 
the framing of the debate in the light of this commitment. Analysis of 
the submissions to the Science and Technology Committee 
consultation had revealed that most people who were against hybrid 
embryo research and motivated enough about the issue to write in 
were also opposed to embryo research using fully human material 
(Joint Committee on the Human Tissue and Embryos (Draft) Bill 
(2007b), pp. 452-454). This appears to have persuaded Government 
that there was little to be gained in allying itself with this constituency,
11 The latter point was given an airing on the Today programme, 26 april 2007. With 
characteristic force, Simon Jenkins stated that 'the process (consultation) is usually 
completely cynical /  A press release from the HFEA on the same day stated that 
public opinion would inform its decision but that it would not determine it; that it was 
important to understand public concerns to help ensure that public 'support and 
trust' in research was maintained. In november 2005, roughly a year before the 
Government proposed a ban, the authority had argued that research using hybrids 
should be allowed under license in its submission to the Departm ent of Health's 
consultation on the Review of the HFE Act.
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and to have encouraged the regulator to frame a consultation with this 
finding in mind, paying little attention to the views of what it now 
believed to be 'the usual suspects'.
That the consultation was led by the HFEA in the light of this analysis 
had consequences. At a public consultation meeting in London 
opponents of embryo research complained that many of the questions 
effectively marginalised their broader views on embryo research, since 
the principled rejection of embryo research regardless of potential 
benefits was not presented as an option. The Chair, Nick Ross, largely 
agreed, but pointed out that those scientists and others who thought 
human or admixed human embryos had no significant moral status, 
that research did not therefore need to justify itself, were also being 
marginalised.
The loss of the latter perspective, arising from the current framing of 
the debate, is often forgotten. In an interview in may 2008, Lisa 
Jardine, Chair of the HFEA, argued that Catholics were the only group 
unable to take part in the national conversation on the governance of 
embryo research on account of their dogmatic views.12 This is only 
true to the extent that those who do not see the need for specific 
governance arrangements accept the terms of debate. The way in 
which scientists and others who make up this group relate to 
engagement processes is an important topic to study -  how does 
engagement function when certain core views are not pressed?
In summary, hybrid embryos were a focus of conflict, an issue over 
which the broader frustrations of many of the actors involved, from 
widely different perspectives, were expressed, and finally one of the 
issues through which the framework underlying the HFE Bill 2008 was 
constructed, as the key players moved towards an accommodation in 
the first half of 2007.
2.4 Conclusion
Drawing together the discussion in sections 2.2 and 2.3 it seems 
reasonable to conclude that the governance framework has lost some 
of its previous focus on the specifics of the embryo and moved towards 
more general rationales for the regulation of novel technologies in 
sensitive areas. The legal and regulatory treatment of human admixed 
embryos, cybrids in particular, could be considered to have played a
12 Available online at: http://w w w .auardian.co.uk/societv/2008/m av/28/health  
(accessed 5 june 2008).
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role in this general shift: though they are regulated as if they are 
equivalent to fully human embryos, their non-viability, and the wide 
range of perspectives on what they are and why we should be 
concerned about them, broadens the class of entities subject to 
regulation and places greater stress on respecting a plurality of views.
Government at first leaned towards connecting with public anxieties 
regarding hybrid embryos, but switched tack when researchers 
accepted the need for regulation and applied pressure within that 
framework, the campaigners against the work proved to be the 'usual 
suspects' and the public, though still concerned, appeared more 
supportive when the possible medical benefits of the work were 
stressed.
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3. Collecting the Data
Up until the end of 2005 I was, through my job, a participant in policy 
debates on embryo research. I continued to follow developments, 
attend events and conferences and occasionally write on the subject 
through the period of intense Parliamentary and public debate in the 
period 2006 up to the present. In sum this research is based, in part, 
on material and insights gained through a participant-observation 
approach.
On-the-record interviews were conducted with the people listed 
immediately below in summer 2008. They lasted between 45 minutes 
and 90 minutes each. With the exception of Calum McKellar, a phone 
interview, they were all conducted face-to-face.
* Dr Calum McKellar, Director of Research, Scottish Council on Human 
Bioethics (http://www.schb.orq.Uk/J
* Martin Johnson, Professor of Reproductive Sciences, University of 
Cambridge ('http://www.pdn.cam.ac.uk/staff/iohnson/index.htm lJ
* Diane Warburton, Director, Shared Practice 
('www.sharedpractice.orq.ukj
* Josephine Quintavalle, Founder and Director, Comment on 
Reproductive Ethics ('h ttp://www.corethics.org/index.phpJ
* Dr Murdo Macdonald, Policy Officer, Science, Religion and 
Technology Project, Church of Scotland 
('http://www.srtp.orq.uk/srtpaqe3.shtm lJ
* Ian Wilmut, Chair of Reproductive Biology and Director, Scottish 
Centre for Regenerative Medicine, University of Edinburgh 
('http://www.scrm.ed.ac.uk/qroup Ian W ilmut.htm lj
* Austin Smith, MRC Research Professor in Stem Cell Biology and 
Director, Wellcome Trust Centre for Stem Cell Research, University of 
Cambridge ('http://www.cscr.cam.ac.uk/asmith.htm lJ
* John Burn, Professor of Clinical Genetics and Executive Director, Life 
Knowledge Park, Newcastle University
('http://www.ncl.ac.uk/biomedicine/research/qroups/profile/iohn.burnJ
The four research scientists are all leading in their fields. They all have 
extensive knowledge and direct experience of working with human 
embryos. While their research interests are related, they are also quite 
distinct from each other's. This allowed me to explore the debate 
about admixed human embryos from different angles. All four have 
many years of experience of working on the issues in the political 
sphere.
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Josephine Quintavalle and Calum McKellar are seasoned writers and 
campaigners. They come from different perspectives but are united by 
a critical perspective on developments in human reproduction and 
embryo research. Murdo Macdonald also has a critical perspective, 
perhaps similar at root to Calum McKellar's. He is however newer to 
this field, which, it seemed, informed a different perspective on some 
issues.
Diane Warburton has an expertise in public participation and in the 
assessment of participation processes. She did an assessment for the 
HFEA of the latter's 2007 public consultation on hybrids and chimeras 
(Warburton, 2007; Human Fertilisation and Embryology Authority,
2007).
Hammersley and Atkinson warn, on the theme of trying to get 'better' 
and more truthful accounts: 'this is important, but it can also be 
problematic: "frankness" may be as much a social accomplishment as 
"discretion"' (Hammersley and Atkinson, 2007, p.49). This is relevant 
on a number of levels for the topic under study; one issue in relation 
to which it seemed particular relevant was the interviews. I decided to 
do the interviews on-the-record because I wanted to be able to discuss 
the specifics of the interviewees' involvement in the events under 
discussion, and to use specific details in the dissertation. As such it 
would be impossible to effectively anonymise them, and any promise 
of doing so would have failed to ring true, resulting in a less rather 
than more open and relaxed discussion.
In addition to the eight interviews I conducted an off-the-record 
interview with David King, Director, Human Genetics Alert 
(h ttp ://w w w .hqalert.org). It  was his preference that it be not 
recorded. Off the record conversations were also held with people from 
the regulator, the HFEA. I failed to persuade them to go on the record. 
In an ideal world I would have interviewed at least one MP involved in 
the debate and perhaps one more stem cell researcher. However, 
given time constraints I decided that it would be better to do this at a 
later stage, after the MRes was completed and the analysis had been 
taken a step further. I have arranged an interview with Ian Gibson MP, 
former chair of the House of Commons Science and Technology 
Committee, for mid October 2008.
In terms of substance, the interviews focused on admixed human 
embryos, the political process, the framework embodied in the HFE Bill 
and the changes and continuities between the 1980s and the 
contemporary debate. However, other issues were touched upon, and
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indeed an interesting aspect of the interviews with the research 
scientists was that the interviewees raised comparisons with the 
political process around the Human Tissue Bill and the nature of the 
Human Tissue Act on several occasions. This is the comparison I plan 
to pursue in the PhD.
There was a general feeling that, from the researcher's point of view, 
the debate around tissue and the subsequent Act had gone quite 
badly. Martin Johnson thought that in comparison the debate on 
human reproduction had gone quite well. He explained the difference 
in part by the activities of the respective scientific communities:
The whole business of how tissues were used by doctors to help 
patients never got articulated, they let the small group of 
patients who were very emotionally aggrieved for entirely 
understandable reasons make the whole case, they didn't go out 
and attempt to engage with them, they just hid from them, in 
shame almost. They shouldn't have done that. They should have 
gone out and said 'some of the things that have been done by 
our colleagues are appalling but the majority of us are not like 
that and this is what is driving us.' That case wasn't really made; 
it just wasn't made. I tore my hair out -  I said to my colleagues 
in pathology 'why aren't you going out defending this, you're 
going to get clobbered if you don't; you have to go out and be 
prepared to take the flak'... In the UK on embryo research there 
wasn't a 'no go area, for the Human Tissue Act there was. You 
couldn't somehow appear to attack grieving parents. They didn't 
need to be attacked, but it could be seen as attack, and you had 
to accept the fact that some people would see it as attack, 
including some parents. People [scientists] didn't adequately 
engage, and they're reaping that harvest. (Interview, Johnson).
John Burn concluded the interview on a critical note about a number of 
regulatory structures, but he also singled out the regulation of tissue:
One of the downsides of the British system is that they do create 
these most elaborate [regulatory] structures, the most dramatic 
of which is the Human Tissue Authority, which has grown out of 
that mad Dutchman in Liverpool and a misinterpretation of the 
Bristol inquiry. We get a knee-jerk response from a few 
politicians and suddenly we've got a Royal Commission and 
suddenly we've got a Human Tissue Authority. We're being 
searched; every office in the NHS was searched for body parts at 
the height of that nonsense. And now we've got this huge,
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elaborate employer of people who come round and inspect all 
our processes for handling tissue samples. They charge us 
thousands upon thousands of pounds for our license. I f  it all 
went away nothing would happen. It's just a process to make 
somebody feel better. (Interview, Burn).
An issue I plan to explore through a comparison of tissue and 
embryology is the question of Government thinking and action: the 
values it sees as important, the choices it makes (including who it 
chooses to listen to and why) and the structures it creates. This theme 
is touched on in this dissertation but will be pursued far more 
substantially through the comparison.
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4. Analysing and Interpreting  the Data
4.1 Continuity between the HFE Act 1990 & the HFE Bill 2008
There was a consensus among the interviewees that the outcome of 
the Parliamentary process was in broad terms predictable. For 
Josephine Quintavalle: 'There have been token gestures towards 
ethical concerns, but the ethical debate, from our perspective, was lost 
in 1990... The Rubicon was crossed in 1990. Since then it has been a 
slippery slope.' (Interview, Quintavalle). From a different perspective 
on some of the moral issues at stake, John Burn agrees. Burn has 
followed the debate for a number of years. He was on the Donaldson 
Committee, which in 2000 advised the Government and Parliament to 
amend the HFE Act 1990 to allow research on embryos aimed at 
understanding embryonic development and to develop embryonic stem 
cell therapies (at the same time as it also recommended a ban on 
hybrid embryo research). He is based in Newcastle and head of the 
Institute where some of the pioneering research has been done on cell 
nuclear replacement research using fully human material and also a 
mixture of animal and human material. He wasn't surprised about the 
furore, but nor was he surprised about the final outcome:
I wasn't that surprised at the reaction we got. I was also not at 
all surprised that we won the Parliamentary debate. Because 
what happened then has happened before: it happened when we 
brought out the stem cell guidance ten years ago and it 
happened in the original Parliamentary debate. A lot of loud 
people make a lot of noise, and then the pragmatic largely 
irreligious British say 'we hear you, but we're not listening'. 
(Interview, Burn).
Quintavalle and Burn not only agree that the outcome was predictable; 
they also agree on a key reason, the medical benefit argument, using 
strikingly similar phrases and categories to describe the process by 
which opinion was shaped, though differences in moral assessment are 
apparent:
You've only got to line up 200 people in wheelchairs who've been 
told they're going to be cured and it's a losing battle... At the 
event organised by Evan Harris outside Parliament [in april 
2008] the BBC interviewed people in wheelchairs in favour of 
hybrid embryo research but not people in wheelchairs opposed. I 
was deeply upset to see them interviewing a young child to 
make the case. We need to be extremely cautious about
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promising a child that he's going to be cured of anything, when 
the reality is that there won't be cures in his lifetime. (Interview, 
Quintavalle).
What I found dramatic about the 2001 stem cell debate, which 
mirrored this one exactly, was that the Lords voted 2: 1 in 
favour. I thought they might be more vulnerable to persuasion. 
When it came down to health benefits the Lords voted 2: 1 in 
favour. So I was never in any great doubt that it would win 
through on this occasion. In some ways, because I thought it 
would go through, I feel a greater sense of responsibility, 
because I think you've basically got a predictability about these 
debates. People who want health related things to go through 
can pretty well guarantee to get them through if you get 
somebody in a wheelchair to go on the television and their mum 
and dad say 'we really hope they can make a treatment'. The 
general power of those arguments is 2: 1 against the religious 
lobby. But that doesn't mean the religious lobby is always wrong. 
So I think we have to use that power with care, because we are 
to some extent in a one party state when it comes to health 
benefits. (Interview, Burn).
In her analysis of the HFEA public consultation on hybrids and 
chimeras (now all classed together as admixed human embryos in the 
language used in the HFE Bill 2008) Diane Warburton, while 
acknowledging the importance of the medical benefit argument, placed 
a great deal of emphasis on the power of deliberation over and above 
anything else. As she stressed during the interview:
When people first think about hybrids many can't help thinking 
about people's heads on animal's bodies. I t  was the medical 
benefits idea that shifted it. But I think it wasn't jus t that, I think 
it was familiarity, in the deliberative process... I t  is the three 
things: the medical benefit; seeing that the scientists are 
reasonable people; and just having the time to think about 
things. With deliberation, because it engages you rationally, logic 
and all those sorts of thing come in, and you're talking to other 
people. (Interview, Warburton).
However, what is striking about the data is that there was as big a 
shift in opinion, in fact a slightly  bigger one, in the opinion poll results 
as there was in the results from the more intense deliberative process. 
In the opinion polling this shift was achieved by simply changing the 
question to stress medical benefit: no discussion or background
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material was involved. When people were asked: 'To what extent do 
you agree or disagree with scientists creating an embryo which 
contains mostly human with a small amount of animal genetic material 
purely for research?' 34% agreed or strongly agreed, while 48% 
disagreed or strongly disagreed. However, when people were asked to 
comment on the following statement: 'I agree with creating embryos 
which contain mostly human and a small amount of animal genetic 
material in research if it may help to understand some diseases for 
example Parkinson's or Motor Neurone Disease.' 61% agreed or 
strongly agreed and 25% disagreed or strongly disagreed.13
4.2 Change: the HFE Act 1990 & the HFE Bill 2008
There was also a strong consensus among the interviewees that the 
framework is evolving, though of course once again different moral 
assessments were made of this. Broadly speaking, the direction is 
away from an embryo centric regulatory system. It is hard to be 
definitive about this, for three reasons: there is a degree of opacity to 
the governance framework; the stated basis of the framework is today 
the same as it was back in the '80s, the special status of the embryo; 
and based on the first two points participants in the debate can choose 
to accentuate or play down aspects of the framework for instrumental 
ends.
These complexities came out in the interviews but so did a broad 
consensus on the overall direction of travel. For Josephine Quintavalle:
In 1990 certain protections for the embryo were taken seriously, 
and there was a big battle, and the clause about embryo 
research having to be necessary is still a part of the law. With 
animal-human hybrids our view is that they are not necessary. 
There's a great difference between 1990 and now, and our battle 
should have been stronger in 1990. Certainly, the conscience of
13 The 61%  figure is, unsurprisingly, the one more commonly referred to by the 
HFEA. This material is taken from a HFEA Authority Paper titled 'Hybrids and 
Chimeras: Findings of the Consultation', Appendix F, Figure 6, authored by Helen 
Coath and presented to the Authority at its 5 September 2007 meeting. I t  was on the 
HFEA website for a while but is no longer there. I have been unable to locate it in 
any web archive so cannot reference it in a publicly accessible form. The paper is 
nearly identical to a public report published by the Authority (Human Fertilisation and 
Embryology Authority, 2007). However, in the published report the public opinion 
polling data is absent. I t  is worth noting that the gulf between the two questions is 
artificially wide: neither represents an accurate picture of the nature of research, one 
being too far to one side (blue skies research); the second too far to the other side 
(an instrumental conception of the nature of research).
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the nation has dulled. There hasn't been any further focus really 
on the rights of the embryo or the value of the human embryo, 
which I find extraordinary in the light of how much we know 
about the human embryo. The likes of John Burn at Newcastle is 
happy to repeat endlessly that the human embryo is just like a 
lump of semolina. I think he's just reinforcing the sense that I 
think many people in the country have about what the embryo is 
about, which is I think extraordinary. (Interview, Quintavalle).
Calum McKellar broadly agreed with this assessment:
In the 1990 Act you still had the influence of the Warnock 
Report, which really was quite strongly in favour of this special 
moral status of the embryo. Whereas in the current Bill I don't 
think the special moral status is mentioned much at all. Basically 
everybody is considered as a pile of cells... In the 1990 debate, 
some people believed that they were piles of cells, but the 
debate was still around the special moral status... I t  is more 
research friendly now. There are different MPs, and people's 
views have changed. (Interview, McKellar).
From the other side of the fence Martin Johnson, while cautious about 
making the point too strongly and reflecting on the issue of whether in 
reality Warnock herself had adopted an embryo centric view, sees a 
similar process at work, an evolutionary process away from what he 
has called the 'tyranny of the embryo' (Johnson, 2006b). In the 
interview he put it like this:
I think there is some ambiguity in the Bill because I think the 
Government was frightened of straying too far from Warnock. 
The fact that the Scrutiny Committee and in fact the Department 
[of Health] really and people in Parliament have said effectively 
that Warnock still provided the moral basis for how we treat the 
embryo is questionable. Mary Warnock herself when we 
interviewed her more or less agreed with that, she said it wasn't 
really about the moral status of the embryo, that was the one 
thing they could never agree on, what they could agree on more 
was on how you treat the embryo. I t  was a very practical 
utilitarian approach. So to that extent I think the current Bill 
does embody the Warnock principle, but not at the level of ethics 
in the strict sense of the word... I think that the current Bill, in 
bringing in the concept of the permitted embryo goes a long way 
along the route I'm talking about. (Interview, Johnson).
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Critics of embryo research see the process of moving away from the 
'tyranny of the embryo' in the substance if not the form of regulation 
as equating to a more research friendly environment. In one sense 
they are clearly right, as Burn acknowledges. But one striking feature 
of the interviews and some of the debates in the various Parliamentary 
Committees is just how frustrated some research scientists are with 
what they perceive to be the failures of the political process, the 
burdens of regulation and its irrational features.
In sections 4.3-4.6 immediately below the hybrids story is retold 
through the words of some of the scientists closely involved in the 
process. This adds to and slightly modifies the analysis of section 2.3 
above, placing the emphasis at least as much on concrete concerns 
linked to the frustrations of practical activity as aspirations deliberately 
to modify the governance framework in the political sphere. This in 
turn lays the basis for an assessment of scientists' approach to 
regulation in this area in 4.7.
4.3 The beginning or the end o f the road for hybrid embryo research?
In the autumn of 2007, Pro-Life campaigners felt they had been 
handed a remarkably powerful propaganda coup. Ian Wilmut, 'father' 
of Dolly the cloned sheep and an internationally renowned pioneer of 
cell nuclear replacement as a research tool for studying human 
diseases, announced he was abandoning the field to pursue what he 
regarded as a superior approach. He had decided to devote all his 
energy to studying the promising approach of induced Pluripotent 
Stem Cells (iPSC), a technique pioneered by Shinya Yamanaka in 
which cells apparently equivalent to embryonic stem cells are produced 
directly from an adult cell nucleus without the creation of an embryo. 
Press commentary suggesting that this might be because Wilmut 
thought it ethically superior as well as scientifically superior was the 
icing on the cake for the critics of hybrid embryo research.
In reality, Wilmut is crystal clear that his shift in focus was not based 
on ethics, and he continues to support all avenues of research:
There is no ethical aspect to this. That's easy [to answer]. I t  was 
a matter of focus. It seemed to me that this was the most likely 
way of achieving our goal, which has proved to be true. But I 
think that human nuclear transfer should continue along with 
other, non-human primate nuclear transfer, to develop the 
technique, because it is never easy to tell how a technique will 
be used. (Interview, Wilmut).
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The real story is Wilmut's and others' struggle to make cloning work, 
caused in part by the burdensome and slow moving nature of the UK 
political and regulatory system. There are other complications as there 
often are in science: scientific competition is involved and, as Wilmut 
freely admits, he was also struggling to cope with an industrial tribunal 
case and new administrative responsibilities. As he said: 'it's  a tale of 
human frailty, and of the complications of research really.' (Wilmut, 
Interview).
In the outline that follows the story is necessarily heavily abbreviated. 
First of all, I consider the competitive aspect, which is influenced by an 
assessment of scientific possibilities and the practicalities of what 
particular teams can hope to achieve.
Wilmut's view is that while there are still worthwhile experiments to 
perform in cloning, it is likely to be judged as a footnote in the history 
of research into embryonic stem cells. Austin Smith, a leading UK 
embryonic stem cell researcher, who, unlike Wilmut, has never been a 
great enthusiast for the merits of cell nuclear replacement research, 
shares this view:
Yamanaka's work is the way forward, almost certainly. It's 
clearly where all the major effort will go. Now, it's always 
possible in science that some roadblock will come up that people 
haven't envisaged. So you never put all your eggs in one basket. 
It  is also possible that things could be learnt from cybrid 
embryos. But it's not obvious why you'd necessarily have to use 
human donor cells; though there could be arguments for it. iPS 
cell technology doesn't mean scientists shouldn't do nuclear 
transfer. I t  ju s t means that we've moved from a position where 
that was the only foreseeable route and everyone knew it was 
deeply unsatisfactory to a position where we can now see a 
much simpler and cleaner route. So it's jus t obvious where you 
put most of your money. (Interview, Smith).
John Burn at Newcastle doesn't necessarily disagree with the point 
about the footnote, but he thinks all research tools might turn out to 
be footnotes. This is where scientific competition enters the story:
Induced pluripotency is a good example of eleven year olds 
playing football. One in goal and ten chase the ball. As soon as 
iPSC came along it was 'let's all rush over there' before they'd 
had a chance to look at the outcome... The problem with the
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induced pluripotency is that there is a bunch of people in 
America in particular who couldn't do hybrid work or human egg 
work so they're bound to say 'this is the greatest thing since 
sliced bread'. The same thing applies to Edinburgh. Edinburgh 
were not well placed to pursue the human embryonic route, so 
inevitably Ian Wilmut's going to say 'we'll try this one' because it 
plays to their strengths. The embryonic one plays to our 
strengths. So we're going to major on that because it gives us 
an edge when it comes to competing for research funds. But 
that's not to exclude everything else. (Interview, Burn).
What Wilmut and Burn agree about is that the best argument for 
pursuing hybrid embryo research is to compare and contrast hybrids 
with fully human material, or with material from the same species.
Burn believes Newcastle scientists are set up well to do that. Wilmut 
on the other hand believes that the time when hybrids embryos were 
most relevant from this point of view was around 2004 or 2005:
To me the significance of the hybrid embryos, if we call them 
that, is probably about three or four years ago... There was a 
time when the cells produced in Shanghai by Professor Sheng 
and her colleagues were the only cells which were approaching 
being equivalent to embryo stem cells that had been produced 
with a human nucleus, and they were produced by putting 
human nuclei into rabbit oocytes. So it seemed important to 
follow that up. The second reason for doing it was that if you 
contrasted what happened during the first 24 hours if you put a 
human nucleus into a rabbit oocyte and a rabbit into a rabbit you 
might learn something about the differences between the species 
which were at that time believed to be unknown but causing the 
failure of primate nuclear transfer. So at that time it seemed a 
very appropriate thing to think of doing, and for that reason it 
may still be appropriate in order to learn about the cloning 
process but I don't see nuclear transfer in this way as having a 
big impact any more.' (Interview, Wilmut).
It was his attempts to do the comparison at the time that brought 
Wilmut up against practical barriers, as Burn suggests, but also 
regulatory and political ones. Wilmut makes the following observation, 
linking his views on the time period in which the work was most 
relevant to his views on the political process:
The political system was slow to deal with this in this country, so 
that by the time that Parliament was debating it we already
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knew from work in Boston that the procedure [admixed cnr] was 
not going to produce embryo stem cell lines very efficiently if at 
all. The thing which was critical to do was to try to repeat 
Sheng's work and to see if it could be improved. The evidence so 
far is that it's difficult to repeat and there's no evidence of 
improvement. But at that point, in the absence of Yamanaka's 
work, it was an important thing to follow. (Interview, Wilmut).
When he tried to investigate fully human cloned embryos and hybrids 
in parallel first one leg of the procedure was hit, then the other.
He had invested a lot of energy in developing a collaboration with the 
South Korean scientist Hwang, who appeared to be doing better work 
in human cloning research than anyone else. When it was discovered, 
in 2005, that many of the results had been faked, it was quite a body 
blow to Wilmut for a whole number of reasons. Not the least of these 
was that he had already spent four years negotiating the regulatory 
and scientific hurdles in an attempt to get to the point where he could 
start to work on cloning using fully human material. But he picked 
himself up, and began discussions with colleagues locally about 
securing a supply of fresh human eggs, only for the other leg of the 
process to be hit:
I went across to the clinic one morning, I thought I'd got animal 
oocyctes in the bag at that point, we were likely to get 
permission... We came up with an algorithm [for the procurement 
of human oocytes] that said roughly that the first six oocytes 
would go to the couple, and then progressively as it went on 
past that we would get more. That conversation was 11 o'clock 
one day. At one o'clock that day I got a phone call from someone 
in the HFEA to inform me that the Government had just 
announced that it was minded to ban the use of animal oocytes... 
it was probably November 2006. I thought 'oh bugger this' and 
sort of lost patience and kept on doing other things. (Interview, 
Wilmut).
One year later his interest ended altogether.
4.4 Hybrids and the political process: the resolution in 2007
Smith picks up the story of what happened when the Government 
announced that it planned to ban work using hybrid embryos late in 
2006:
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The Government White Paper saying they would ban this area 
was jus t gob-smacking... If  you talk to the public, and ask, is it 
better to put a woman through hormonal stimulation to get 
human eggs or should you go down to the abattoir and get cow 
eggs? It's  a no brainer. So why do we get so exercised? It's just 
a very, very bizarre place to be in I think. (Interview, Smith)
In response to this, says Smith, scientists had to make a number of 
pragmatic decisions. One was to work within the framework of UK law, 
though he demurs at the suggestion that this entailed expressing 
strong support for the HFEA:
You're faced with the reality of UK law, that the way to deal with 
that situation is to get these things recognised as human 
embryos so they can be licensed for research. I f  you don't do 
that, there's a problem... From the point of view of the scientists 
you jus t want to do the bloody experiment. When these kinds of 
situations arise, and you suddenly find there's some political 
threat, some regulatory threat, then all you're interested in is 
finding your way round that... the key thing was to have these 
entities recognised as human embryos and therefore covered by 
the Act, and unfortunately that means we have to take the HFEA 
as well! So it was a marriage of convenience I suppose. I guess 
that may also be why any criticism of the HFEA was rather 
muted, because the key point was to have these entities 
recognised under the Act, and therefore it would be difficult to 
argue at the same time that we should get rid of the HFEA, 
although I still think logically that you could have argued that, 
but apparently not to politicians. (Interview, Smith).
Smith also makes a distinction, to explain who was defending what 
during the discussions in the first half of 2007:
For me it [hybrid embryo research] was symbolically important 
to protect but not practically. Many of the other scientists started 
off from the position that this was practically important to 
protect. This was a rapidly changing time in science. The 
implications of Yamanaka, people just hadn't realised.
(Interview, Smith).
Yamanaka's work is mentioned only very briefly in the hearings. 
Developing the point about defending the principle as opposed to 
defending the actual research, in Smith's view there was a reason for
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4.6 Simply the best?
Scientists disagree and will continue to disagree on the most promising 
avenues of scientific research, but they clearly agreed on the necessity 
to defend the principle of research. Given the problems they had 
experienced it is no surprise that a number of scientists also reject the 
claim made by Government and the regulator that the UK leads the 
world in regulation and research.
During the Scrutiny Committee discussions, Committee member (Lord) 
Professor Winston was a lone voice challenging the Government view: 
'America has an unregulated scientific community and yet it is 
producing by far the most effective and most published and most 
respected papers in stem cell biology in the world, even though of 
course it has a President who is set against i t /  (Joint Committee on 
the Human Tissue and Embryos (Draft) Bill (2007b), p. 66).
However, others concur with his assessment on the relationship 
between the UK system and innovation. Austin Smith is very 
forthright:
I can't see any credible basis for claiming that the UK is in any 
kind of leading position in human embryo research in terms of 
the science... in practical terms it's not easy to do in the UK, and 
we've lost out because of that actually compared with other 
countries... It's  not even just the private sector in the US, it's 
just non-NIH funded, so there's Howard Hughes and JDRF and 
many others. There are other European countries like Belgium 
and Sweden where they have good quality IVF clinics with a 
reasonable level of research going on. In the UK it really hasn't 
happened. That may be to do with broader issues than the 
regulatory framework. I t  may be to do with the way that IVF is 
funded in this country and the separation of clinical treatment 
from research, which is an issue throughout the NHS. But the 
idea of the HFEA having a role in the UK supposedly leading the 
world in stem cell research is farcical... the HFEA reasonably 
enough wants to bang its own drum and politicians like to have 
something to bang their drum about. They still seem to be 
obsessed by the idea that somehow we're ahead of the US 
because of the Federal ban on funding. Any idiot could just look 
at the amount of funding from other sources going into this area 
in the US, the number of researchers, any metric you want to 
use -  it's clear. (Interview, Smith).
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the low profile given to Yamanaka's work beyond the fact that his work 
using human cells had not been published at the time:
The context of the hearings was to defend this area of research 
[hybrids] so you didn't actually want to say at this point, well, 
you know, here's a new technology that is the way forward so 
we don't need this any more because, you know, you'd be 
shooting yourself in the foot. (Interview, Smith).
4.5 The mediating role o f the AMS and the Scrutiny Committee
I t  was not jus t that scientists rebelled against the idea of banning 
research and wanted to fight for the principle that research that 
carried no risk of harm should be allowed. Instinctively scientists were 
also unhappy because they felt that complete ignorance of biology was 
leading to an attempt to impose rigid, notions, rigid categories on 
complex biological phenomena. Professor Martin Bobrow put it 
succinctly, and a little tactfully, during an evidence session to inform 
the Science and Technology Committee's inquiry on the subject:
There is a huge gradation of everything from a single gene in an 
otherwise completely mouse cell to the reciprocal, and 
somewhere along there we have to draw a line. The definitions 
of humanity that I know about all apply to things that walk upon 
the earth rather than things that live on the bottom of the Petrie 
dish and I am not sure that there is a straightforward answer [to 
the question of whether hybrids are human or not]. (House of 
Commons Science and Technology Committee (2007b), p. Ev 
38).
A counter discourse to the political view that hybrids are a distinct 
category requiring clear definition and sensitive treatment became 
somewhat public in this way and in particular through the Academy of 
Medical Science's publication Inter-species embryos (The Academy of 
Medical Sciences, 2007) produced by a Committee chaired by Bobrow. 
This was wrapped up with scientists' desire to carve out a publicly 
recognised space for their expertise and autonomy. The convergence 
of the two strands, the mediation of them, was through the Scrutiny 
Committee's idea that discretion should be given to the regulator to 
work with scientists in licensing novel applications, and that in 
principle most conceivable forms of human or admixed human embryo 
should be able to be created for research purposes. Further public and 
Parliamentary controversy was to follow, but at the level of political 
deal making this resolved the issue.
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4.7 Scientists and regulation
What does this recent history of conflict over hybrid embryo research 
tell us about scientists' attitudes towards regulation in this area? As 
Mulkay tells the story, in the 1980s, a number of individual scientists, 
many eminent in the field, as well as some scientific institutions and 
journals at an editorial level, opposed the framework outlined by 
Warnock. Robert Edwards, IVF pioneer, responded in this way: 'I  deny 
the argument that [the] scientific impetus will necessarily lead to silly 
experiments. I t  would be unwise to jeopardise future advances by 
short-term recourse to the criminal law.' Another prominent researcher 
thought that 'the first part of the report is practical and sensible 
because it was based on at least 10 years of experience [with IVF]. 
When you come to the regulation of research it draws on science 
fiction and so is tinged with hysteria.' (Mulkay, 1997, p. 21).
But, continues Mulkay, when they saw the way the political wind was 
blowing they fell in behind Warnock in the hope and expectation that 
regulation of research would provide some political protection for their 
work. As one MP put it: 'the Medical Research Council recanted and 
threw its full weight behind Warnock.' (Mulkay, 1997, p. 27).
Mulkay's discussion of the process gives the impression of a volte-face, 
and implies a compliment about scientists' tactical sense. But if it is a 
compliment, it is one that Johnson suspects may be a back-handed 
one. Johnson, an active participant in the debates of the 1980s, resists 
the idea that it was primarily an instrumental move by scientists. Yes, 
scientists did scheme, he argues, but substantially what they did was 
to throw the decision open to society and lay out the options -  out of 
this they expected regulations to emerge:
I don't think we tried to push the research argument, we just 
pointed out what had happened as a result of research and the 
consequences of banning further research. I don't think we were 
dishonest at all in that. (Interview, Johnson).
Indeed, going further back in time, this is how Johnson believes 
Edwards approached the issue in the 1970s, and how he believes most 
scientists approach the issue today:
He didn't resist regulation, you don't see him out there resisting 
regulation, he wanted to have the debate in society, he was 
trying to get society to discuss this rationally for years before it
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did, until Louise Brown was born, and then it [society] did 
because it could suddenly see there was something to discuss 
and so on... the majority of scientists and doctors are perfectly 
happy to be regulated as long as it's done reasonably, and they 
can see that there is a genuine public concern. I think apart from 
the odd one or two they are broadly of the view that as long as 
regulation is done intelligently and in an informed way with 
widespread debate, then it's perfectly fine. You may kick against 
it, you may get irritated by it and you may criticise it, but all of 
that is legitimate, because it is never going to be perfect and you 
have to be articulating your concerns.' (Interview, Johnson).
Perhaps not surprisingly, former chair of the HFEA Ruth Deech is more 
sympathetic to Mulkay's (implied) argument. In what reads like a 
direct rejoinder to Johnson she argues that in a key paper Johnson 
refers to (Edwards and Sharpe, 1971) 'Edwards was perhaps 
committed to the facilitation of science rather than to the imposition of 
restraints based on public concerns.' (Deech and Smajdor, 2007, p. 
29). She develops this point, generalising to broader medical and 
scientific opinion:
His [Edwards'] ambivalent attitude towards regulation was 
revealed when he later described state interference in 
reproductive medicine as 'Nazism and Stalinism'. I f  nothing else, 
this illustrates the way scientific and medical support for 
regulation fluctuates in relation to what the scientists may 
regard as the imperative for freedom in research. (Deech and 
Smajdor, 2007, p. 29).
This discussion and dispute between Mulkay, Johnson and Deech tells 
us something interesting and useful about the approach of scientists to 
the regulatory process and the governance framework, in addition to 
their concerns and frustrations.
Johnson's approach is that it is reasonable and fair to push the 
boundaries of public opinion: one should operate at that point, neither 
behind it nor too far ahead of it. In his view the Department of Health 
was behind it and the Scrutiny Committee in the right place in the 
struggle to frame the new Bill. By implication the Science and 
Technology Committee was too far ahead of it in its 2005 report.
Exactly who was pursuing what, when and why are matters of 
judgement. Issues of temperament and views on the way the political 
process should work are clearly crucial. The history of the hybrids
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debate suggests that for that community of scientists in the first half 
of 2007 the instrumental approach to regulation was clearly present. 
Furthermore, while Johnson speaks of it being reasonable to kick 
against the framework others seem to speak more strongly.
However, scientists aren't instinctive political radicals any more than 
anyone else. A distinction needs to be made between their personal 
views, the views they express in public even, and the extent to which 
they are inclined or willing to really pursue such ideas in the political 
sphere. In large part the main concern of many, in Smith's words, is to 
'do the bloody experiment'. Johnson's view is too rosy and reasonable 
sounding, but he is right to say that scientists rarely reject regulation 
as a mater of principle. Rather, more typically, they resent the implied 
criticism involved in the idea of specific regulation while also holding 
out the hope for an idealised, smooth and efficient system of 
regulation, rather than rejecting regulation as such.
4.8 The political process and regulation: all eyes on the HFEA?
The tendency to use the governance framework as a resource rather 
than to debate its merits in the political realm has ultimately reinforced 
a pattern of continuity in regulatory structures. Connected to this the 
strong sentiment that the outcome of the Parliamentary process was 
predictable led all the parties to focus a significant degree of attention 
on the regulatory process throughout the period of debate in the 
political sphere.
For the critics of embryo research, because they felt and feel that their 
ability to influence political decision-making is limited, in many ways 
the long game was always to focus on regulation. For example, 
Quintavalle, through Court cases, campaigning activity and dialogue if 
she can get it is seeking to use the notion that embryo research must 
be considered 'necessary' in order to lim it research applications.
On the other side Evan Harris MP has led a campaigning machine 
during the Parliamentary debates on the Bill, one that has won the 
admiration of Josephine Quintavalle and teasing comments from 
Government Ministers, who suggested he was developing an 
alternative career as a Parliamentary draftsman. However, 
notwithstanding Quintavalle's observation, Harris has also bowed to 
political realities and retreated from the more radical proposals 
contained in the report of the House of Commons Science and 
Technology published in 2005 that he championed. In Parliamentary 
debate in 2008 he suggested that if no one was happy with the
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framework for embryo research it must be right, a comment meant 
somewhat ironically no doubt, but an interesting one nonetheless.14
In summary, once liberal critics such as Harris along with scientists 
had come to the conclusion that they would not be able explicitly to 
shake up the process of regulation, they adopted a similar approach to 
that of Josephine Quintavalle and settled down to work with the 
regulator.
14 Commons Hansard, 19 may 2008, column 53.
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5. Findings
That the existing framework was used as a resource in the debate over 
hybrids rather than being discussed on its merits led to or reinforced a 
trend towards a diminution in the specificity of governance 
arrangements in this area. At no point was there a real or substantive 
argument or discussion of the merits of embryo research using fully 
human material. This process of normalisation was further 
strengthened by the fact that the debate that did occur, the debate in 
which embryos were to some degree considered, was over hybrid 
embryos, embryos that are not viable in most cases. The issues 
considered in this context were more to do with human dignity and 
slippery slopes on the one side, and medical benefits on the other. 
Human embryos were swept up in this debate through the process of 
either considering hybrid embryos to be explicitly human (the HFEA's 
approach) or else deserving of identical or near identical regulation 
(the approach in the HFE Bill 2008).
The Government transferred the issue further away from the nature of 
the entities being regulated, and at the same time neutered any 
substantive debate, by stressing that a primary rationale for regulation 
and restriction was to create a space for and to respect a plurality of 
views.
Scientists are escaping 'the tyranny of the embryo' through a slow 
evolutionary process, but this is perhaps cold comfort for at least some 
research scientists. The flip side of the lack of a principled debate is 
that 'freedom to research' was not pressed either. One consequence of 
this is that while critics argue that researchers can 'get away with 
anything', researchers are in fact far from happy. They had to fight 
over something they hoped they wouldn't have needed to. When the 
dust settled, what had they got? Regulatory restrictions based on 
respecting a plurality of views may be no less onerous than those 
based on respecting the embryo, while the specific restrictions on 
hybrids seem perverse to practising scientists. How the regulation of 
admixed human embryo research will develop in practice remains an 
open question. John Burn suggests that 'had it been any other 
scientific procedure it [the regulation] would have slackened off a bit, 
but I think it will get the full fury of bureaucratic regulation, potentially 
more so [than fully human material].' (Interview, Burn),
If that turns out to be the case scientists will reflect that regulations on 
this issue at least are particularly burdensome and irrational. What 
seems fairly clear is that at the moment at least, scientists at the
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coalface do not support claims by the Government and the regulator 
that the UK is the best of all possible places to do embryo research. Its 
virtue is said to be that the UK system contains tensions, but are some 
of those tensions imagined? I f  there were greater 'freedom to 
research' would it really bring the public-opinion house down?
The political messages sent from Parliament are very important, as are 
detailed changes proposed to regulation contained in the Bill, but in 
contemporary practice this reinforces the fact that the HFEA is the only 
game in town. For this reason, despite their criticisms of the regulatory 
framework and the regulator most participants in the debate either 
need or want to work with it. The inability or unwillingness of the 
parties to challenge the framework is its ultimate source of strength. 
This allows Government and the regulator a degree of choice in the 
values it promotes and the decisions it takes.
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